Cloudbreak Pharma Inc. (HKG:2592)

Cloudbreak Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Operating Revenue	10	10	-	-
Other Revenue	0.24	0.21	0.88	0.47
Revenue	10.24	10.21	0.88	0.47
Revenue Growth (YoY)	2074.52%	1060.68%	86.84%	-
Gross Profit	10.24	10.21	0.88	0.47
Selling, General & Admin	14.04	9.49	11.28	8.91
Research & Development	39.19	37.95	27.49	15.29
Other Operating Expenses	-0.06	0	-0.01	-0.04
Operating Expenses	53.17	47.44	38.76	24.16
Operating Income	-42.92	-37.22	-37.88	-23.69
Interest Expense	-0.03	-0.03	-0.28	-0.03
Interest & Investment Income	1.3	2.03	3.87	1.6
Currency Exchange Gain (Loss)	-0.74	0.65	0.66	0.62
Other Non Operating Income (Expenses)	1.48	-63.72	-95.78	-45.31
EBT Excluding Unusual Items	-40.91	-98.3	-129.4	-66.81
Gain (Loss) on Sale of Investments	-	-	-	0.06
Gain (Loss) on Sale of Assets	-	-	-	-0
Pretax Income	-40.91	-98.3	-129.4	-66.76
Income Tax Expense	0.93	0.83	0.02	0.08
Net Income	-41.83	-99.13	-129.42	-66.84
Net Income to Common	-41.83	-99.13	-129.42	-66.84
Shares Outstanding (Basic)	475	475	463	459
Shares Outstanding (Diluted)	475	475	463	459
Shares Change (YoY)	3.66%	2.78%	0.86%	-
EPS (Basic)	-0.09	-0.21	-0.28	-0.15
EPS (Diluted)	-0.17	-0.21	-0.28	-0.15
Free Cash Flow	-26.28	-26.68	-23.06	-20.83
Free Cash Flow Per Share	-0.06	-0.06	-0.05	-0.04
Gross Margin	100.00%	100.00%	100.00%	100.00%
Operating Margin	-419.10%	-364.43%	-4304.20%	-5029.09%
Profit Margin	-408.45%	-970.53%	-14706.59%	-14190.66%
Free Cash Flow Margin	-256.59%	-261.18%	-2620.68%	-4422.08%
EBITDA	-42.34	-36.35	-37.38	-23.55
D&A For EBITDA	0.58	0.87	0.5	0.14
EBIT	-42.92	-37.22	-37.88	-23.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.